(Q24246991)

2 July 2019

meta-analysis

0 references

review article

1 reference

title

Tiotropium for stable chronic obstructive pulmonary disease (English)

1 reference

2 July 2019

chronic obstructive pulmonary disease

main subject

0 references

1

R G Barr

R G

Barr

1 reference

2 July 2019

3

C A Camargo

C A

Camargo

1 reference

2 July 2019

J Bourbeau

2

J

Bourbeau

1 reference

2 July 2019

F S F Ram

series ordinal

4

author given names

F S F

author last names

Ram

1 reference

2 July 2019

publication date

18 April 2005

1 reference

2 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

2 July 2019

issue

2

1 reference

2 July 2019

page(s)

CD002876

1 reference

2 July 2019

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Tolerance to bronchodilating effects of salmeterol in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Minimal important difference of the transition dyspnoea index in a multinational clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Does pulmonary rehabilitation give additional benefit over tiotropium therapy in primary care management of chronic obstructive pulmonary disease? Randomized controlled clinical trial in Hong Kong Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

The effect of tiotropium on exacerbations and airflow in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Hospitalizations and mortality in the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

The pharmacological properties of tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Tiotropium versus placebo for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Contemporary management of chronic obstructive pulmonary disease: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002876.PUB2

Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease

21 January 2018

1 reference

12 December 2020

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group

1 reference

12 December 2020

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000

1 reference

12 December 2020

Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?

1 reference

12 December 2020

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial

1 reference

12 December 2020

Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD

1 reference

12 December 2020

Tiotropium improves FEV1 in patients with COPD irrespective of smoking status

1 reference

12 December 2020

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.

1 reference

12 December 2020

Ba 679 Br, a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study in COPD

1 reference

12 December 2020

Management of chronic obstructive pulmonary disease

1 reference

12 December 2020

Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group

1 reference

12 December 2020

Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma

1 reference

12 December 2020

10.1002/14651858.CD002876.PUB2

Identifiers

DOI

1 reference

2 July 2019

release_dcvetscs6vg5xay2xybp36jena

Fatcat ID

0 references

OpenCitations bibliographic resource ID

2422645

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

2 July 2019

PubMed publication ID

15846642

1 reference

2 July 2019